294 related articles for article (PubMed ID: 32084434)
21. Sensing environmental lipids by dendritic cell modulates its function.
Coutant F; Agaugué S; Perrin-Cocon L; André P; Lotteau V
J Immunol; 2004 Jan; 172(1):54-60. PubMed ID: 14688309
[TBL] [Abstract][Full Text] [Related]
22. Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE.
Wu R; Svenungsson E; Gunnarsson I; Andersson B; Lundberg I; Schäfer Elinder L; Frostegård J
Lupus; 1999; 8(2):142-50. PubMed ID: 10192509
[TBL] [Abstract][Full Text] [Related]
23. Effect of lysophosphatidylcholine on the structure and function of low density lipoproteins.
Korotaeva AA; Cheglakov IB; Morozkin AD; Suslova IV; Prokazova NV
Membr Cell Biol; 1997; 10(5):521-34. PubMed ID: 9225256
[TBL] [Abstract][Full Text] [Related]
24. Lysophosphatidylcholine triggers cell differentiation in the protozoan parasite Herpetomonas samuelpessoai through the CK2 pathway.
Dutra FL; Vieira DP; Coelho FS; Adade CM; Atella GC; Silva Neto MAC; Lopes AH
Acta Parasitol; 2020 Mar; 65(1):108-117. PubMed ID: 31755068
[TBL] [Abstract][Full Text] [Related]
25. Human group X secreted phospholipase A2 induces dendritic cell maturation through lipoprotein-dependent and -independent mechanisms.
Atout R; Karabina SA; Dollet S; Carreras M; Payré C; André P; Lambeau G; Lotteau V; Ninio E; Perrin-Cocon L
Atherosclerosis; 2012 Jun; 222(2):367-74. PubMed ID: 22494626
[TBL] [Abstract][Full Text] [Related]
26. Modified lipoproteins provide lipids that modulate dendritic cell immune function.
Perrin-Cocon L; Diaz O; André P; Lotteau V
Biochimie; 2013 Jan; 95(1):103-8. PubMed ID: 22959067
[TBL] [Abstract][Full Text] [Related]
27. Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes.
Sevastou I; Kaffe E; Mouratis MA; Aidinis V
Biochim Biophys Acta; 2013 Jan; 1831(1):42-60. PubMed ID: 22867755
[TBL] [Abstract][Full Text] [Related]
28. LOX-1 mediates lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells.
Aoyama T; Chen M; Fujiwara H; Masaki T; Sawamura T
FEBS Lett; 2000 Feb; 467(2-3):217-20. PubMed ID: 10675541
[TBL] [Abstract][Full Text] [Related]
29. Modulation of nonselective cation current by oxidized LDL and lysophosphatidylcholine and its inhibitory contribution to endothelial damage.
Liang GH; Park S; Kim MY; Kim JA; Choi S; Suh SH
Life Sci; 2010 May; 86(19-20):733-9. PubMed ID: 20226792
[TBL] [Abstract][Full Text] [Related]
30. Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes.
Han MS; Park SY; Shinzawa K; Kim S; Chung KW; Lee JH; Kwon CH; Lee KW; Lee JH; Park CK; Chung WJ; Hwang JS; Yan JJ; Song DK; Tsujimoto Y; Lee MS
J Lipid Res; 2008 Jan; 49(1):84-97. PubMed ID: 17951222
[TBL] [Abstract][Full Text] [Related]
31. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium- dependent relaxation.
Murohara T; Kugiyama K; Ohgushi M; Sugiyama S; Ohta Y; Yasue H
Am J Physiol; 1994 Dec; 267(6 Pt 2):H2441-9. PubMed ID: 7810742
[TBL] [Abstract][Full Text] [Related]
32. Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4.
Qiao J; Huang F; Naikawadi RP; Kim KS; Said T; Lum H
Am J Physiol Lung Cell Mol Physiol; 2006 Jul; 291(1):L91-101. PubMed ID: 16461426
[TBL] [Abstract][Full Text] [Related]
33. Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells.
Jougasaki M; Kugiyama K; Saito Y; Nakao K; Imura H; Yasue H
Circ Res; 1992 Sep; 71(3):614-9. PubMed ID: 1499109
[TBL] [Abstract][Full Text] [Related]
34. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells.
Aoyama T; Fujiwara H; Masaki T; Sawamura T
J Mol Cell Cardiol; 1999 Dec; 31(12):2101-14. PubMed ID: 10640439
[TBL] [Abstract][Full Text] [Related]
35. Endothelins specifically recognize lysophosphatidylcholine micelles.
Sato A; Ebina K
J Pept Sci; 2013 Jun; 19(6):355-61. PubMed ID: 23576491
[TBL] [Abstract][Full Text] [Related]
36. A model to study physiological activation of phospholipase A2 and vasorelaxation by lysophosphatidylcholine.
Menon NK; Pataricza J; Zehetgruber M; Bing RJ
Life Sci; 1990; 47(21):1941-8. PubMed ID: 2266777
[TBL] [Abstract][Full Text] [Related]
37. Lipoprotein-associated phospholipase A2 decreases oxidized lipoprotein cellular association by human macrophages and hepatocytes.
Yang M; Chu EM; Caslake MJ; Edelstein C; Scanu AM; Hill JS
Biochim Biophys Acta; 2010 Feb; 1801(2):176-82. PubMed ID: 19895904
[TBL] [Abstract][Full Text] [Related]
38. Transactivation of fetal liver kinase-1/kinase-insert domain-containing receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation.
Fujita Y; Yoshizumi M; Izawa Y; Ali N; Ohnishi H; Kanematsu Y; Ishizawa K; Tsuchiya K; Tamaki T
Endocrinology; 2006 Mar; 147(3):1377-85. PubMed ID: 16322069
[TBL] [Abstract][Full Text] [Related]
39. Fatty acyl composition of lysophosphatidylcholine is important in atherosclerosis.
Akerele OA; Cheema SK
Med Hypotheses; 2015 Dec; 85(6):754-60. PubMed ID: 26604024
[TBL] [Abstract][Full Text] [Related]
40. Lysophosphatidylcholine-induced cytotoxicity and protection by heparin in mouse brain bEND.3 endothelial cells.
Tsai TY; Leong IL; Cheng KS; Shiao LR; Su TH; Wong KL; Chan P; Leung YM
Fundam Clin Pharmacol; 2019 Feb; 33(1):52-62. PubMed ID: 29974515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
